Treatment of BRAF inhibitor-induced hyperkeratosis. (Record no. 22123555)

MARC details
000 -LEADER
fixed length control field 01449 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516112717.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201310s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1651-226X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.3109/0284186X.2012.716165
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Battley, Jodie E
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20131031
245 00 - TITLE STATEMENT
Title Treatment of BRAF inhibitor-induced hyperkeratosis.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Acta oncologica (Stockholm, Sweden)
Date of publication, distribution, etc. May 2013
300 ## - PHYSICAL DESCRIPTION
Extent 874-7 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Case Reports; Letter
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anti-Inflammatory Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clobetasol
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Head and Neck Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Imidazoles
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Keratoderma, Palmoplantar
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Melanoma
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oximes
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein Kinase Inhibitors
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Proto-Oncogene Proteins B-raf
General subdivision antagonists & inhibitors
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lenihan, Elizabeth
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Redmond, Henry P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Murphy, Michelle
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Power, Derek G
773 0# - HOST ITEM ENTRY
Title Acta oncologica (Stockholm, Sweden)
Related parts vol. 52
-- no. 4
-- p. 874-7
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.3109/0284186X.2012.716165">https://doi.org/10.3109/0284186X.2012.716165</a>
Public note Available from publisher's website

No items available.